Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations
2024-01-01 Valerio, Matteo; Inno, Alessandro; Zambelli, Alberto; Cortesi, Laura; Lorusso, Domenica; Viassolo, Valeria; Verzè, Matteo; Nicolis, Fabrizio; Gori, Stefania
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey
2024-01-01 Mongelli, Michele; Lorusso, Domenica; Zanagnolo, Vanna; Pignata, Sandro; Colombo, Nicoletta; Cormio, Gennaro
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
2024-01-01 Olawaiye, Alexander B.; Kim, Jae-Weon; Bagameri, Andrea; Bishop, Erin; Chudecka-Głaz, Anita; Devaux, Alix; Gladieff, Laurence; Gordinier, Mary E.; Korach, Jacob; Mccollum, Michael E.; Mileshkin, Linda; Monk, Bradley J.; Nicum, Shibani; Nogueira-Rodrigues, Angélica; Oaknin, Ana; O'Malley, David M.; Orlando, Mauro; Dreiling, Lyndah; Tudor, Iulia C.; Lorusso, Domenica
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients
2024-01-01 Bruno, M.; Apostol, A. I.; Boccia, S. M.; Sassu, C. M.; Lardino, S.; Culcasi, C.; Lorusso, D.; Scambia, G.; Fagotti, A.; Marchetti, C.
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
2024-01-01 Passarelli, Anna; Carbone, Vittoria; Pignata, Sandro; Mazzeo, Roberta; Lorusso, Domenica; Scambia, Giovanni; Canova, Stefania; Di Palma, Teresa; Tasca, Giulia; Mantiero, Mara; Naglieri, Emanuele; Andreetta, Claudia; Rauso, Martina; Brunetti, Anna Elisabetta; Laera, Letizia; Abeni, Chiara; Scandurra, Giuseppa; Gambaro, Anna Rita; Pastore, Alessia; Bengala, Carmelo; Gunnellini, Marco; Farolfi, Alberto; Spinello, Maurizio; Bartoletti, Michele
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
2023-01-01 Cibula, David; Rosaria Raspollini, Maria; Planchamp, François; Centeno, Carlos; Chargari, Cyrus; Felix, Ana; Fischerová, Daniela; Jahnn-Kuch, Daniela; Joly, Florence; Kohler, Christhardt; Lax, Sigurd; Lorusso, Domenica; Mahantshetty, Umesh; Mathevet, Patrice; Raj Naik, Mr; Nout, Remi A; Oaknin, Ana; Peccatori, Fedro; Persson, Jan; Querleu, Denis; Rubio Bernabé, Sandra; Schmid, Maximilian P.; Stepanyan, Artem; Svintsitskyi, Valentyn; Tamussino, Karl; Zapardiel, Ignacio; Lindegaard, Jacob Christian
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
2024-01-01 Pignata, S.; Califano, D.; Lorusso, D.; Arenare, L.; Bartoletti, M.; De Giorgi, U.; Andreetta, C.; Pisano, C.; Scambia, G.; Lombardi, D.; Farolfi, A.; Cinieri, S.; Passarelli, A.; Salutari, V.; De Angelis, C.; Mignogna, C.; Priolo, D.; Capoluongo, E. D.; Tamberi, S.; Scaglione, G. L.; Arcangeli, V.; De Cecio, R.; Scognamiglio, G.; Greco, F.; Spina, A.; Turinetto, M.; Russo, D.; Carbone, V.; Casartelli, C.; Schettino, C.; Perrone, F.
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
2024-01-01 Lorusso, Domenica; Raspagliesi, Francesco; Ronzulli, Dominique; Valabrega, Giorgio; Colombo, Nicoletta; Pisano, Carmela; Cassani, Chiara; Tognon, Germana; Tamberi, Stefano; Mangili, Giorgia; Mammoliti, Serafina; De Giorgi, Ugo; Greco, Filippo; Mosconi, Anna Maria; Breda, Enrico; Artioli, Grazia; Andreetta, Claudia; Casanova, Claudia; Ceccherini, Rita; Frassoldati, Antonio; Salutari, Vanda; Giolitto, Serena; Scambia, Giovanni
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
2022-01-01 Bartoletti, Michele; Pignata, Sandro; Lorusso, Domenica; Perrone, Francesco; Zara, Diego; Puglisi, Fabio
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023-01-01 Matulonis, Ursula A.; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A.; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G.; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael; Coleman, Robert L.
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial
2024-01-01 Roma, Cristin; Esposito Abate, Riziero; Sacco, Alessandra; Califano, Daniela; Arenare, Laura; Bergantino, Francesca; Pisano, Carmela; Cecere, Sabrina Chiara; Scambia, Giovanni; Lorusso, Domenica; Artioli, Grazia; Tasca, Giulia; Spina, Anna; Russo, Daniela; Gadducci, Angiolo; De Angelis, Carmine; Bologna, Alessandra; Marchini, Sergio; Capoluongo, Ettore Domenico; Perrone, Francesco; Pignata, Sandro; Normanno, Nicola
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
2023-01-01 Forlani, Luca; De Cecco, Loris; Simeon, Vittorio; Paolini, Biagio; Bagnoli, Marina; Cecere, Sabrina Chiara; Spina, Anna; Citeroni, Eleonora; Bignotti, Eliana; Lorusso, Domenica; Arenare, Laura; Russo, Daniela; De Angelis, Carmine; Ardighieri, Laura; Scognamiglio, Giosuè; Del Sesto, Michele; Tognon, Germana; Califano, Daniela; Schettino, Clorinda; Chiodini, Paolo; Perrone, Francesco; Mezzanzanica, Delia; Pignata, Sandro; Tomassetti, Antonella
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary
2024-01-01 González-Martín, Antonio; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney; Lorusso, Domenica; Mccormick, Colleen C; Freyer, Gilles; Backes, Floor; Heitz, Florian; Redondo, Andrés; Moore, Richard G; Vulsteke, Christof; O'Cearbhaill, Roisin E; Malinowska, Izabela A; Shtessel, Luda; Compton, Natalie; Mirza, Mansoor R; Monk, Bradley J
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023-01-01 González-Martín, A.; Harter, P.; Leary, A.; Lorusso, D.; Miller, R. E.; Pothuri, B.; Ray-Coquard, I.; Tan, D. S. P.; Bellet, E.; Oaknin, A.; Ledermann, J. A.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
2023-01-01 Koppikar, S.; Oaknin, A.; Babu, K. Govind; Lorusso, D.; Gupta, S.; Wu, L. -Y.; Rajabto, W.; Harano, K.; Hong, S. -H.; Malik, R. A.; Strebel, H.; Aggarwal, I. M.; Lai, C. -H.; Dejthevaporn, T.; Tangjitgamol, S.; Cheng, W. F.; Chay, W. Y.; Benavides, D.; Hashim, N. M.; Moon, Y. W.; Yunokawa, M.; Anggraeni, T. D.; Wei, W.; Curigliano, G.; Maheshwari, A.; Mahantshetty, U.; Sheshadri, S.; Peters, S.; Yoshino, T.; Pentheroudakis, G.
Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary
2024-01-01 Moore, Kathleen N.; Lorusso, Domenica; Oaknin, Ana; Oza, Amit; Colombo, Nicoletta; Van Gorp, Toon; O'Malley, David M.; Banerjee, Susana; Murphy, Conleth G.; Harter, Philipp; Konecny, Gottfried E.; Pautier, Patricia; Method, Michael; Wang, Yuemei; Coleman, Robert L.; Birrer, Michael; Matulonis, Ursula A.
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
2024-01-01 Salani, Ritu; Mccormack, Mary; Kim, Yong-Man; Ghamande, Sharad; Hall, Shaundra L.; Lorusso, Domenica; Barraclough, Lisa; Gilbert, Lucy; Guzman Ramirez, Adrian; Lu, Chien-Hsing; Sabatier, Renaud; Colombo, Nicoletta; Hu, Youyou; Krishnan, Venkatesh; Molinero, Luciana; Feng, Yuning; Kim, Nicole; Castro, Marcela; Lin, Yvonne G.; Monk, Bradley J.; Foote, Janie
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification
2023-01-01 Perrone, Emanuele; Capasso, Ilaria; De Felice, Francesca; Giannarelli, Diana; Dinoi, Giorgia; Petrecca, Alessandro; Palmieri, Luca; Foresta, Aniello; Nero, Camilla; Arciuolo, Damiano; Lorusso, Domenica; Zannoni, Gian Franco; Scambia, Giovanni; Fanfani, Francesco
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study
2024-01-01 Berton, Dominique; Pautier, Patricia; Lorusso, Domenica; Gennigens, Christine; Gladieff, Laurence; Kryzhanivska, Anna; Bowman, Jill; Tian, Chuan; Cornfeld, Mark; Van Gorp, Toon
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
2023-01-01 Arezzo, Francesca; Giannone, Gaia; Castaldo, Daniele; Scotto, Giulia; Tuninetti, Valentina; Turinetto, Margherita; Bartoletti, Michele; Mammoliti, Serafina; Artioli, Grazia; Mangili, Giorgia; Salutari, Vanda; Lorusso, Domenica; Cormio, Gennaro; Loizzi, Vera; Zamagni, Claudio; Savarese, Antonella; Di Maio, Massimo; Ronzino, Graziana; Pisano, Carmela; Pignata, Sandro; Valabrega, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations | 1-gen-2024 | Valerio, Matteo; Inno, Alessandro; Zambelli, Alberto; Cortesi, Laura; Lorusso, Domenica; Viassolo, Valeria; Verzè, Matteo; Nicolis, Fabrizio; Gori, Stefania | |
| Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey | 1-gen-2024 | Mongelli, Michele; Lorusso, Domenica; Zanagnolo, Vanna; Pignata, Sandro; Colombo, Nicoletta; Cormio, Gennaro | |
| Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer | 1-gen-2024 | Olawaiye, Alexander B.; Kim, Jae-Weon; Bagameri, Andrea; Bishop, Erin; Chudecka-Głaz, Anita; Devaux, Alix; Gladieff, Laurence; Gordinier, Mary E.; Korach, Jacob; Mccollum, Michael E.; Mileshkin, Linda; Monk, Bradley J.; Nicum, Shibani; Nogueira-Rodrigues, Angélica; Oaknin, Ana; O'Malley, David M.; Orlando, Mauro; Dreiling, Lyndah; Tudor, Iulia C.; Lorusso, Domenica | |
| Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients | 1-gen-2024 | Bruno, M.; Apostol, A. I.; Boccia, S. M.; Sassu, C. M.; Lardino, S.; Culcasi, C.; Lorusso, D.; Scambia, G.; Fagotti, A.; Marchetti, C. | |
| Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity | 1-gen-2024 | Passarelli, Anna; Carbone, Vittoria; Pignata, Sandro; Mazzeo, Roberta; Lorusso, Domenica; Scambia, Giovanni; Canova, Stefania; Di Palma, Teresa; Tasca, Giulia; Mantiero, Mara; Naglieri, Emanuele; Andreetta, Claudia; Rauso, Martina; Brunetti, Anna Elisabetta; Laera, Letizia; Abeni, Chiara; Scandurra, Giuseppa; Gambaro, Anna Rita; Pastore, Alessia; Bengala, Carmelo; Gunnellini, Marco; Farolfi, Alberto; Spinello, Maurizio; Bartoletti, Michele | |
| ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023 | 1-gen-2023 | Cibula, David; Rosaria Raspollini, Maria; Planchamp, François; Centeno, Carlos; Chargari, Cyrus; Felix, Ana; Fischerová, Daniela; Jahnn-Kuch, Daniela; Joly, Florence; Kohler, Christhardt; Lax, Sigurd; Lorusso, Domenica; Mahantshetty, Umesh; Mathevet, Patrice; Raj Naik, Mr; Nout, Remi A; Oaknin, Ana; Peccatori, Fedro; Persson, Jan; Querleu, Denis; Rubio Bernabé, Sandra; Schmid, Maximilian P.; Stepanyan, Artem; Svintsitskyi, Valentyn; Tamussino, Karl; Zapardiel, Ignacio; Lindegaard, Jacob Christian | |
| MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy | 1-gen-2024 | Pignata, S.; Califano, D.; Lorusso, D.; Arenare, L.; Bartoletti, M.; De Giorgi, U.; Andreetta, C.; Pisano, C.; Scambia, G.; Lombardi, D.; Farolfi, A.; Cinieri, S.; Passarelli, A.; Salutari, V.; De Angelis, C.; Mignogna, C.; Priolo, D.; Capoluongo, E. D.; Tamberi, S.; Scaglione, G. L.; Arcangeli, V.; De Cecio, R.; Scognamiglio, G.; Greco, F.; Spina, A.; Turinetto, M.; Russo, D.; Carbone, V.; Casartelli, C.; Schettino, C.; Perrone, F. | |
| Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial | 1-gen-2024 | Lorusso, Domenica; Raspagliesi, Francesco; Ronzulli, Dominique; Valabrega, Giorgio; Colombo, Nicoletta; Pisano, Carmela; Cassani, Chiara; Tognon, Germana; Tamberi, Stefano; Mangili, Giorgia; Mammoliti, Serafina; De Giorgi, Ugo; Greco, Filippo; Mosconi, Anna Maria; Breda, Enrico; Artioli, Grazia; Andreetta, Claudia; Casanova, Claudia; Ceccherini, Rita; Frassoldati, Antonio; Salutari, Vanda; Giolitto, Serena; Scambia, Giovanni | |
| Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer | 1-gen-2022 | Bartoletti, Michele; Pignata, Sandro; Lorusso, Domenica; Perrone, Francesco; Zara, Diego; Puglisi, Fabio | |
| Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study | 1-gen-2023 | Matulonis, Ursula A.; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A.; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G.; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael; Coleman, Robert L. | |
| Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trial | 1-gen-2024 | Roma, Cristin; Esposito Abate, Riziero; Sacco, Alessandra; Califano, Daniela; Arenare, Laura; Bergantino, Francesca; Pisano, Carmela; Cecere, Sabrina Chiara; Scambia, Giovanni; Lorusso, Domenica; Artioli, Grazia; Tasca, Giulia; Spina, Anna; Russo, Daniela; Gadducci, Angiolo; De Angelis, Carmine; Bologna, Alessandra; Marchini, Sergio; Capoluongo, Ettore Domenico; Perrone, Francesco; Pignata, Sandro; Normanno, Nicola | |
| Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial | 1-gen-2023 | Forlani, Luca; De Cecco, Loris; Simeon, Vittorio; Paolini, Biagio; Bagnoli, Marina; Cecere, Sabrina Chiara; Spina, Anna; Citeroni, Eleonora; Bignotti, Eliana; Lorusso, Domenica; Arenare, Laura; Russo, Daniela; De Angelis, Carmine; Ardighieri, Laura; Scognamiglio, Giosuè; Del Sesto, Michele; Tognon, Germana; Califano, Daniela; Schettino, Clorinda; Chiodini, Paolo; Perrone, Francesco; Mezzanzanica, Delia; Pignata, Sandro; Tomassetti, Antonella | |
| Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary | 1-gen-2024 | González-Martín, Antonio; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney; Lorusso, Domenica; Mccormick, Colleen C; Freyer, Gilles; Backes, Floor; Heitz, Florian; Redondo, Andrés; Moore, Richard G; Vulsteke, Christof; O'Cearbhaill, Roisin E; Malinowska, Izabela A; Shtessel, Luda; Compton, Natalie; Mirza, Mansoor R; Monk, Bradley J | |
| Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up | 1-gen-2023 | González-Martín, A.; Harter, P.; Leary, A.; Lorusso, D.; Miller, R. E.; Pothuri, B.; Ray-Coquard, I.; Tan, D. S. P.; Bellet, E.; Oaknin, A.; Ledermann, J. A. | |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer | 1-gen-2023 | Koppikar, S.; Oaknin, A.; Babu, K. Govind; Lorusso, D.; Gupta, S.; Wu, L. -Y.; Rajabto, W.; Harano, K.; Hong, S. -H.; Malik, R. A.; Strebel, H.; Aggarwal, I. M.; Lai, C. -H.; Dejthevaporn, T.; Tangjitgamol, S.; Cheng, W. F.; Chay, W. Y.; Benavides, D.; Hashim, N. M.; Moon, Y. W.; Yunokawa, M.; Anggraeni, T. D.; Wei, W.; Curigliano, G.; Maheshwari, A.; Mahantshetty, U.; Sheshadri, S.; Peters, S.; Yoshino, T.; Pentheroudakis, G. | |
| Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary | 1-gen-2024 | Moore, Kathleen N.; Lorusso, Domenica; Oaknin, Ana; Oza, Amit; Colombo, Nicoletta; Van Gorp, Toon; O'Malley, David M.; Banerjee, Susana; Murphy, Conleth G.; Harter, Philipp; Konecny, Gottfried E.; Pautier, Patricia; Method, Michael; Wang, Yuemei; Coleman, Robert L.; Birrer, Michael; Matulonis, Ursula A. | |
| A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04) | 1-gen-2024 | Salani, Ritu; Mccormack, Mary; Kim, Yong-Man; Ghamande, Sharad; Hall, Shaundra L.; Lorusso, Domenica; Barraclough, Lisa; Gilbert, Lucy; Guzman Ramirez, Adrian; Lu, Chien-Hsing; Sabatier, Renaud; Colombo, Nicoletta; Hu, Youyou; Krishnan, Venkatesh; Molinero, Luciana; Feng, Yuning; Kim, Nicole; Castro, Marcela; Lin, Yvonne G.; Monk, Bradley J.; Foote, Janie | |
| Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification | 1-gen-2023 | Perrone, Emanuele; Capasso, Ilaria; De Felice, Francesca; Giannarelli, Diana; Dinoi, Giorgia; Petrecca, Alessandro; Palmieri, Luca; Foresta, Aniello; Nero, Camilla; Arciuolo, Damiano; Lorusso, Domenica; Zannoni, Gian Franco; Scambia, Giovanni; Fanfani, Francesco | |
| Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study | 1-gen-2024 | Berton, Dominique; Pautier, Patricia; Lorusso, Domenica; Gennigens, Christine; Gladieff, Laurence; Kryzhanivska, Anna; Bowman, Jill; Tian, Chuan; Cornfeld, Mark; Van Gorp, Toon | |
| Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors | 1-gen-2023 | Arezzo, Francesca; Giannone, Gaia; Castaldo, Daniele; Scotto, Giulia; Tuninetti, Valentina; Turinetto, Margherita; Bartoletti, Michele; Mammoliti, Serafina; Artioli, Grazia; Mangili, Giorgia; Salutari, Vanda; Lorusso, Domenica; Cormio, Gennaro; Loizzi, Vera; Zamagni, Claudio; Savarese, Antonella; Di Maio, Massimo; Ronzino, Graziana; Pisano, Carmela; Pignata, Sandro; Valabrega, Giorgio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27915
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269650
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19969
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25662
- reserved1362
- open891